| PI-3065 |
PI-3065 |
955977-50-1 |
| Danirixin |
GSK1325756 |
954126-98-8 |
| KKL-10 |
952849-76-2 |
952849-76-2 |
| 951654-29-8 |
(3-5-(1-羟基-1-甲基乙基)-1H-苯并咪唑-1-基][1,1'-联苯基]-2-甲酰胺 |
951654-29-8 |
| NS 11394 |
3'-[5-(1-羟基-1-甲基乙基)-1H-苯并咪唑-1-基]-[1,1'-联苯]-2-甲腈 |
951650-22-9 |
| Liproxstatin-1 |
利普司他丁-1 |
950455-15-9 |
| E6005 |
E6005 |
947620-48-6 |
| LY2409881 trihydrochloride |
IKK2抑制剂（LY2409881） |
946518-60-1 |
| FPH2 |
FPH2 |
957485-64-2 |
| XL019 |
XL019 |
945755-56-6 |
| GSK 189254 |
6-[(3-环丁基-2,3,4,5-四氢-1H-3-苯并氮杂卓-7-基)氧基]-N-甲基-3-吡啶甲酰胺盐酸盐 |
945493-87-8 |
| BKM120 (NVP-BKM120, Buparlisib) |
BKM-120 |
944396-07-0 |
| BMS 303141 |
BMS303141 |
943962-47-8 |
| 4-((2-(((1R,2R)-2-hydroxycyclohexyl)aMino)benzo[d]thiazol-6-yl)oxy)-N-MethylpicolinaMide |
BLZ945 |
953769-46-5 |
| Ruxolitinib |
鲁索利替尼 |
941678-49-5 |
| SCH772984 |
(R)-1-(2--2-氧(4-(4-(嘧啶-2-基)苯基)对二氮己环-1-基)乙基)-N-(3-(吡啶-4-基)-1H--5INDAZOL-基)吡咯烷-3-甲酰胺 |
942183-80-4 |
| CARBAMIC ACID, N-[2-[(R)-(3-CHLOROPHENYL)[(3R)-1-[[[(2S)-2-(METHYLAMINO)-3-[(3R)-TETRAHYDRO-2H-PYRAN-3-YL]PROPYL]AMINO]CARBONYL]-3-PIPERIDINYL]METHOXY]ETHYL]-, METHYL ESTER |
N-[2-[(R)-(3-氯苯基)[(3R)-1-[[[(2S)-2-(甲基氨基)-3-[(3R)-四氢-2H-吡喃-3-基]丙基]氨基]羰基]-3-哌啶基]甲氧基]乙基]氨基甲酸甲酯 |
942142-51-0 |
| ReModelin |
REMODELIN |
949912-58-7 |
| TB5 |
TB5 |
948841-07-4 |
| LCZ696 |
LCZ696 |
936623-90-4 |
